Rybelsus is now the first and only oral glucagon-like peptide 1 receptor agonist (GLP-1 RA), mimicking a natural hormone in the body that helps regulate blood sugar, appetite, and digestion, available in the EU for type 2 diabetes with a proven cardiovascular benefit
The expected price reductionpotentially exceeding 7090%is particularly significant
Healthcare professionals play a key role in determining the right maintenance dose for each patient
Final pricing, applicable taxes, and plan details are confirmed at checkout
Real Certificate of Analysis from Baltic Peptides View all COAs In stock now at our partner Baltic Peptides - GLP-1/GIP/glucagon triple agonist
doi:10.1177/1933719115602772 [50] Agarwal A, Sengupta P, Durairajanayagam D